OPEN MONOCLONAL TECHNOLOGY INC.;WUXI BIOLOGICS (CAYMAN) INC
发明人:
申请号：
IL25706218
公开号：
IL257062D0
申请日:
2018.01.21
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
The present disclosure provides monoclonal antibodies against protein programmed cell death 1 (PD-1), which an block the binding of PD-1 ligands to PD-1, and therefore block the inhibitory function of PD-1 ligands on PD-1 expressing T cells. The antibodies of disclosure provide very potent agents for the treatment of multiple cancers via modulating human immune function.
